QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
NASDAQ:CLSD

Clearside Biomedical News Headlines

$3.45
+0.14 (+4.23 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.30
Now: $3.45
$3.71
50-Day Range
$3.07
MA: $3.65
$4.25
52-Week Range
$1.10
Now: $3.45
$4.53
Volume489,483 shs
Average Volume987,421 shs
Market Capitalization$166.82 million
P/E RatioN/A
Dividend YieldN/A
Beta1.42

Headlines

Clearside Biomedical (NASDAQ CLSD) News Headlines Today

Source:
SourceHeadline
-$0.13 Earnings Per Share Expected for Clearside Biomedical, Inc. (NASDAQ:CLSD) This Quarter-$0.13 Earnings Per Share Expected for Clearside Biomedical, Inc. (NASDAQ:CLSD) This Quarter
americanbankingnews.com - March 1 at 6:14 AM
Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday, March 10, 2021Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday, March 10, 2021
finance.yahoo.com - February 24 at 9:47 AM
Clearside Biomedical (NASDAQ:CLSD) Stock Price Down 7.9%Clearside Biomedical (NASDAQ:CLSD) Stock Price Down 7.9%
americanbankingnews.com - February 23 at 7:42 PM
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021
finance.yahoo.com - February 23 at 8:38 AM
Wedbush Reaffirms "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)Wedbush Reaffirms "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)
americanbankingnews.com - February 20 at 1:34 PM
Clearside Biomedical (NASDAQ:CLSD) Trading 11% Higher Clearside Biomedical (NASDAQ:CLSD) Trading 11% Higher
americanbankingnews.com - February 19 at 7:01 PM
Clearside Biomedical, Inc. (NASDAQ:CLSD) Director Clay Thorp Sells 32,873 SharesClearside Biomedical, Inc. (NASDAQ:CLSD) Director Clay Thorp Sells 32,873 Shares
americanbankingnews.com - February 12 at 7:16 PM
Xenon Pharmaceuticals (NASDAQ:XENE) vs. Clearside Biomedical (NASDAQ:CLSD) Head to Head SurveyXenon Pharmaceuticals (NASDAQ:XENE) vs. Clearside Biomedical (NASDAQ:CLSD) Head to Head Survey
americanbankingnews.com - February 12 at 6:20 PM
Wedbush Reiterates "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)Wedbush Reiterates "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)
americanbankingnews.com - February 10 at 12:41 PM
Clearside Biomedical (NASDAQ:CLSD) Trading 12.4% Higher Clearside Biomedical (NASDAQ:CLSD) Trading 12.4% Higher
americanbankingnews.com - February 8 at 8:04 PM
Clearside Biomedicals (CLSD) Shares March Higher, Can It Continue?Clearside Biomedical's (CLSD) Shares March Higher, Can It Continue?
finance.yahoo.com - February 2 at 9:41 AM
BioMedNewsBreaks - Clearside Biomedical Inc. (NASDAQ: CLSD) Closes Sale of Common Stock for $12MBioMedNewsBreaks - Clearside Biomedical Inc. (NASDAQ: CLSD) Closes Sale of Common Stock for $12M
marketwatch.com - January 29 at 2:09 PM
Did You Miss Clearside Biomedicals (NASDAQ:CLSD) 41% Share Price Gain?Did You Miss Clearside Biomedical's (NASDAQ:CLSD) 41% Share Price Gain?
finance.yahoo.com - January 18 at 6:20 PM
Implied Volatility Surging for Clearside Biomedical (CLSD) Stock OptionsImplied Volatility Surging for Clearside Biomedical (CLSD) Stock Options
finance.yahoo.com - January 14 at 5:42 PM
Are You Looking for a Top Momentum Pick? Why Clearside Biomedical, Inc. (CLSD) is a Great ChoiceAre You Looking for a Top Momentum Pick? Why Clearside Biomedical, Inc. (CLSD) is a Great Choice
finance.yahoo.com - January 13 at 2:44 PM
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMDClearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
finance.yahoo.com - January 12 at 10:41 AM
Clearside Biomedical Announces Pricing of $12 Million Registered Direct OfferingClearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
finance.yahoo.com - January 6 at 7:59 AM
Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publication on the Suprachoroidal Injection Procedure in Translational Vision Science and TechnologyClearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publication on the Suprachoroidal Injection Procedure in Translational Vision Science and Technology
finance.yahoo.com - November 16 at 9:32 AM
Clearside Biomedical to Present at the Stifel 2020 Virtual Healthcare ConferenceClearside Biomedical to Present at the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 11 at 9:13 AM
Clearside Biomedical EPS beats by $0.06, beats on revenueClearside Biomedical EPS beats by $0.06, beats on revenue
seekingalpha.com - November 10 at 7:37 PM
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate UpdateClearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 7:37 PM
Clearside Biomedical IncClearside Biomedical Inc
bloomberg.com - October 31 at 12:48 PM
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
finance.yahoo.com - October 30 at 9:58 AM
Clearside Biomedical (CLSD) Enters Oversold TerritoryClearside Biomedical (CLSD) Enters Oversold Territory
finance.yahoo.com - October 27 at 7:19 AM
Clearside Biomedical presents at the Retina Society 2020 and publication of XIPERE dataClearside Biomedical presents at the Retina Society 2020 and publication of XIPERE data
seekingalpha.com - September 23 at 11:15 AM
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® forClearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for
bloomberg.com - September 11 at 8:24 PM
Dosing is underway for Clearside/Aura Biosciencess AU-011 in mid-stage study for eye cancerDosing is underway for Clearside/Aura Biosciences's AU-011 in mid-stage study for eye cancer
seekingalpha.com - September 11 at 10:23 AM
Mid-stage study underway on eye drug administered with Clearside microinjectorMid-stage study underway on eye drug administered with Clearside microinjector
seekingalpha.com - September 11 at 10:23 AM
Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal DeliveryClearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery
finance.yahoo.com - September 11 at 10:23 AM
Clearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment ConferenceClearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 9 at 6:05 PM
Clearside Biomedical’s licensing partner doses first patient in its Phase 2 therapy trial, shares rallies 13%Clearside Biomedical’s licensing partner doses first patient in its Phase 2 therapy trial, shares rallies 13%
seekingalpha.com - September 9 at 1:05 PM
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal DeliveryClearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery
finance.yahoo.com - September 9 at 1:05 PM
Have Insiders Been Buying Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares?Have Insiders Been Buying Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares?
finance.yahoo.com - September 2 at 9:31 AM
Clearside Bio nabs new patents in U.S. and EuropeClearside Bio nabs new patents in U.S. and Europe
seekingalpha.com - August 26 at 9:05 AM
Clearside Biomedical Expands Patent Portfolio in the U.S. and EuropeClearside Biomedical Expands Patent Portfolio in the U.S. and Europe
finance.yahoo.com - August 26 at 9:05 AM
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q2 2020 Results - Earnings Call TranscriptClearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 11:09 PM
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue EstimatesClearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 11:09 PM
Clearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal SpaceClearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space
finance.yahoo.com - August 10 at 6:09 PM
Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateClearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 10 at 6:09 PM
Clearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceClearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 7:43 AM
Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseClearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
nasdaq.com - August 3 at 3:20 PM
Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseClearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 3 at 3:20 PM
Clearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020Clearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020
finance.yahoo.com - July 30 at 9:19 AM
Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseClearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 29 at 1:55 PM
Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual MeetingClearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting
finance.yahoo.com - July 27 at 8:08 AM
Clearside Biomedical, Inc. Common Stock (CLSD) - Institutional OwnershipClearside Biomedical, Inc. Common Stock (CLSD) - Institutional Ownership
www.fool.com - July 27 at 12:28 AM
Clearside Biomedical, Inc. (CLSD) Upgraded to Buy: Heres What You Should KnowClearside Biomedical, Inc. (CLSD) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - June 22 at 5:55 PM
Clearside Biomedical, Inc. (CLSD) Upgraded to Buy: Here's What You Should KnowClearside Biomedical, Inc. (CLSD) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - June 22 at 5:55 PM
Clearside Biomedical Announces Numerous Presentations at the ARVO 2020 MeetingClearside Biomedical Announces Numerous Presentations at the ARVO 2020 Meeting
finance.yahoo.com - June 17 at 7:45 AM
Hedge Funds Warming Up To Clearside Biomedical, Inc. (CLSD) Again?Hedge Funds Warming Up To Clearside Biomedical, Inc. (CLSD) Again?
finance.yahoo.com - June 4 at 7:31 PM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.